RAS (KRAS OR NRAS) GENE MUTATION
Clinical trials for RAS (KRAS OR NRAS) GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new RAS (KRAS OR NRAS) GENE MUTATION trials appear
Sign up with your email to follow new studies for RAS (KRAS OR NRAS) GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets Hard-to-Treat cancers with MAPK mutations
Disease control Recruiting nowThis early-phase trial tests an experimental oral drug, NST-628, in adults with advanced solid tumors that have specific genetic changes in the MAPK pathway and have stopped responding to standard treatments. The study aims to find a safe dose and check for early signs of tumor s…
Matched conditions: RAS (KRAS OR NRAS) GENE MUTATION
Phase: PHASE1 • Sponsor: Nested Therapeutics, Inc • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Massive canadian study hunts rare cancer mutations for better treatments
Knowledge-focused Recruiting nowThis study follows 5,500 Canadian cancer patients whose tumors have rare genetic changes. Researchers will collect data on how these cancers behave and how well different treatments work, including newer targeted drugs. The goal is to learn more about these uncommon mutations to …
Matched conditions: RAS (KRAS OR NRAS) GENE MUTATION
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC